PHV-wordings
Here you will find safety-relevant information that must be implemented in the corresponding product information due to a PHV (pharmacovigilance) issues.
Due to the relaunch of the EMA website in December 2023, you will find the current links to the entries prior to December 01, 2023 at https://www.ema.europa.eu
Search narrowed by
Varicella vaccine (live) New
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Selegiline New
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Rocuronium New
PSUR-outcome
|
09/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Rifampicin New
PSUR-outcome
|
08/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Prazepam New
PSUR-outcome
|
08/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Metoprolol New
PSUR-outcome
|
07/01/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amplodipine/Atorvastatin
PSUR-outcome
|
15/12/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Propylthiouracil
PSUR-outcome
|
03/12/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Vancomycin
PSUR-outcome
|
02/12/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Codeine
PSUR-outcome
|
28/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
